GLP-1 Revolution, Non-Traditional Delivery, and Telehealth Expansion
HIT Consultant
FEBRUARY 28, 2024
The Centers for Disease Control and Prevention estimates that obesity accounts for $147 billion in annual healthcare costs, an amount which could be greatly lowered through use of the new drugs. GLP-1 medications have also been shown to improve outcomes for patients with diabetes, heart disease and other chronic conditions.
Let's personalize your content